1-7 of 7
axitinib
Close
Sort by
Journal Articles

Effect of Avelumab to Immune Response in AML: A Phase I Study of Avelumab in Combination with Decitabine As First Line Treatment of Unfit Patients

Hong Zheng, MD PhD, Shin Mineishi, David F. Claxton, MD, Junjia Zhu, Chenchen Zhao, MD, Bei Jia, MD PhD, W. Christopher Ehmann, MD, Seema Naik, MD, Natthapol Songdej, Raymond J. Hohl
Journal: Blood
Blood (2019) 134 (Supplement_1): 3939.
https://doi.org/10.1182/blood-2019-125153
Published: 2019
Journal Articles

Concurrent Treatment of VEGFR Tyrosine Kinase Inhibitors (TKIs) and Factor Xa Inhibitors Is Associated with Increased Bleeding Risks

Sandip Patel, MBBS, Tiffany George, MD, Tzu-Fei Wang, MD MPH, Sherry Mori Vogt, Pharm D, Edmund Folefac, MD, Ming Yin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3681.
https://doi.org/10.1182/blood-2019-130465
Published: 2019
Journal Articles

Identification of Targeted Therapies for Rare Adult Mature T-Cell Leukemia Using Functional Ex Vivo Screening of Primary Patient Samples

Uma Borate, MD, Brianna A. Norris, Pierrette Lo, MS, Cristina E. Tognon, Brian Junio, Jeffrey W. Tyner, Brian J. Druker, MD
Journal: Blood
Blood (2016) 128 (22): 4720.
https://doi.org/10.1182/blood.V128.22.4720.4720
Published: 2016
Journal Articles

Anti-Leukemic Activity of Axitinib Against Cells Harboring the BCR-ABL Point Mutation

Seiichi Okabe, MD PhD, Tetsuzo Tauchi, MDPhD, Yuko Tanaka, MDPhD, Juri Sakuta, MD PhD, Kazuma Ohyashiki, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2769.
https://doi.org/10.1182/blood.V126.23.2769.2769
Published: 2015
Journal Articles

Development of a Clinically Relevant in Vitro Drug Screening Platform for Chemo-Refractory AML Patients

Stephen Sze Yuen Lam, Chae Yin Cher, Nelson Ka Lam Ng, Eric SK Ho, Cheuk Him Man, PhD, Howard CH Chow, Connie J Eaves, Alice MS Cheung, PhD, Anskar Y.H. Leung, MD
Journal: Blood
Blood (2014) 124 (21): 3624.
https://doi.org/10.1182/blood.V124.21.3624.3624
Published: 2014
Journal Articles

Renal Medullary Carcinoma in an Adolescent with Homozygous Hemoglobin SS

Anne M. Marsh, MD, Keith C. Quirolo, MD, Carla Golden, MD, Elliott Vichinsky, MD
Journal: Blood
Blood (2012) 120 (21): 4774.
https://doi.org/10.1182/blood.V120.21.4774.4774
Published: 2012
Journal Articles

Tyrosine Kinase Inhibitor Screen Identifies the Multikinase Inhibitor, Foretinib, As a Sensitisor of Treatment-resistant B-Precursor ALL to Core Chemotherapeutic Agents

Shaun R Wilson, MBChB, MRCPCH, Victoria J Weston, PhD, Tatjana Stankovic, MD, PhD, Pamela R Kearns, BSc, MBBCh, MRCP, PhD
Journal: Blood
Blood (2011) 118 (21): 1509.
https://doi.org/10.1182/blood.V118.21.1509.1509
Published: 2011